Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
3.010
0.00 (0.00%)
At close: Jan 14, 2026, 4:00 PM EST
3.050
+0.040 (1.33%)
After-hours: Jan 14, 2026, 7:54 PM EST
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $167.6 million as of January 14, 2026. Its market cap has increased by 117.66% in one year.
Market Cap
167.60M
Enterprise Value
159.31M
1-Year Change
117.66%
Ranking
Category
Stock Price
$3.01
Market Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.58M to $167.60M, a decrease of -80.41%. That is a compound annual growth rate of -21.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 167.60M | -10.15% |
| Dec 31, 2025 | 186.53M | 126.70% |
| Dec 31, 2024 | 82.28M | 82.80% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.91B |
| Johnson & Johnson | 505.28B |
| AbbVie | 388.90B |
| UnitedHealth Group | 308.45B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 271.01B |
| Novo Nordisk | 263.26B |